-
Ultimovacs Announces UV1 Data Presentation at Upcoming 2021 ASCO Annual Meeting
-
Ultimovacs ASA – Share Option Program
-
Ultimovacs ASA – Annual General Meeting held on 15 April 2021
-
Ultimovacs ASA – Disclosure of voting rights of Annual General Meeting
-
Ultimovacs Presents the INITIUM Study Design as a Trial-in-Progress Poster at AACR Annual Meeting 2021
-
Ultimovacs ASA: Notice of Annual General Meeting on 15 April 2021
-
Ultimovacs ASA: Annual Report 2020
-
Ultimovacs ASA: New share capital registered
-
Ultimovacs ASA: Share capital increase related to exercise of options
-
Ultimovacs Starts Clinical Evaluation of Novel TET-Platform with Phase I TENDU Study Investigating Prostate Cancer-Specific Therapeutic Vaccine
